Medicare Enrolled
Dr. Joel Lardizabal, M.D.
Cardiovascular Disease · San Luis Obispo, CA
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lardizabal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lardizabal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lardizabal
Dr. Joel Lardizabal is a cardiovascular disease specialist in San Luis Obispo, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lardizabal performed 5,884 Medicare services across 4,487 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lardizabal received a total of $8,878 from 26 pharmaceutical and/or device companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lardizabal is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 15% volume in CA
$8,878 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,884
Medicare services
Top 15% in CA for cardiovascular disease
4,487
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~310 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,075 | $90 | $298 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
529 | $11 | $58 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
473 | $87 | $276 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
405 | $42 | $155 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
315 | $8 | $44 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
304 | $119 | $456 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
278 | $17 | $70 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
239 | $371 | $1,360 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
236 | $52 | $272 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
223 | $9 | $44 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
216 | $108 | $706 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
199 | $136 | $401 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
176 | $19 | $77 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
138 | $21 | $100 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
133 | $20 | $81 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
109 | $18 | $74 |
| New patient office visit, complex (60-74 min) | 105 | $161 | $573 |
| Cardiac catheterization | 98 | $192 | $920 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
68 | $25 | $81 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
64 | $16 | $99 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
61 | $10 | $36 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
52 | $24 | $118 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
47 | $10 | $48 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
40 | $26 | $181 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
37 | $419 | $1,734 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
30 | $57 | $272 |
| Additional heart vessel ultrasound evaluation An ultrasound evaluation of an additional heart blood vessel performed during a diagnostic or treatment procedure. |
27 | $41 | $219 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
27 | $121 | $701 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $285 | $1,153 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
20 | $74 | $272 |
| Additional heart vessel ultrasound evaluation An additional ultrasound assessment of a specific heart blood vessel or graft, including radiologist review. |
20 | $59 | $219 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
19 | $134 | $766 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
18 | $19 | $75 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
18 | $24 | $98 |
| Permanent leadless pacemaker insertion A small, self-contained pacemaker is placed directly into the heart without using wires. The procedure is guided by imaging to ensure correct positioning. |
14 | $371 | $1,401 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
14 | $127 | $754 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
12 | $43 | $213 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
12 | $20 | $147 |
| Transcatheter aortic valve replacement via femoral artery A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery. |
11 | $585 | $3,879 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.9% high complexity
25.6% medium
62.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,878
Total received (2018-2024)
Avg $1,268/year across 7 years
Top 29% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,851 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$669
2023
$563
2022
$577
2021
$2,273
2020
$2,237
2019
$1,287
2018
$1,273
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$244
Amgen Inc.
$120
Abbott Laboratories
$89
Edwards Lifesciences Corporation
$81
Novartis Pharmaceuticals Corporation
$59
iRhythm Technologies, Inc.
$28
AstraZeneca Pharmaceuticals LP
$27
Boston Scientific Corporation
$22
Top 3 companies account for 67.6% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,833
Edwards Lifesciences Corporation
$1,721
Medtronic, Inc.
$1,654
Abbott Laboratories
$611
Kowa Pharmaceuticals America, Inc.
$584
Novartis Pharmaceuticals Corporation
$497
Boston Scientific Corporation
$253
Amarin Pharma Inc.
$248
Medtronic Vascular, Inc.
$235
Janssen Pharmaceuticals, Inc
$135
AtriCure, Inc.
$134
ABIOMED
$130
Esperion Therapeutics, Inc.
$112
iRhythm Technologies, Inc.
$103
Medical Device Business Services, Inc.
$92
Regeneron Healthcare Solutions, Inc.
$89
Boehringer Ingelheim Pharmaceuticals, Inc.
$82
ASAHI INTECC USA, INC.
$78
PFIZER INC.
$73
AstraZeneca Pharmaceuticals LP
$60
Braemar Manufacturing, LLC
$35
E.R. Squibb & Sons, L.L.C.
$32
Digirad Corporation
$24
ARBOR PHARMACEUTICALS, INC.
$23
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$23
CARDIVA MEDICAL, INC.
$17
Top 3 companies account for 58.7% of all-time payments
Associated products mentioned in payments ›
AMPLATZER TALISMAN · ANDEXXA · ASAHI PTCA Guide Wire · ATRICURE SYNERGY ABLATION SYSTEM · Assurity Pacemaker · Attain · BRILINTA · CARDIVA VASCADE MVP VVCS 6-12F · COREVALVE EVOLUT R · Cardiac Monitoring Suite · Cardius 3m · CareLink · Claria MRI · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EUPHORA · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Ellipse ICD · Endurant · Fortify Assura · Impella · JARDIANCE · LEQVIO · LINQ II · LifeVest · Livalo · MICRA · Merlin Connectivity and Remote · Micra · NEXLIZET · ONYX FRONTIER · PRADAXA · PRALUENT ALIROCUMAB INJECTION · Pacemakers · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · Repatha · Resolute · Reveal LINQ · Rotablator Rotational Atherectomy System Console Kit · SAPIEN 3 Ultra RESILIA · SYMPLICITY G3 · TELESCOPE · Unify Assura CRT Defibrillator · Vascepa · WATCHMAN · WATCHMAN FLX · XARELTO · ZIO Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
17
Per 100K population
6.0
County median income
$93,398
Nearest hospital
FRENCH HOSPITAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lardizabal is a remote & cardiac specialist, with above-average Medicare volume (top 15% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lardizabal experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Lardizabal performed 1,075 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lardizabal receive payments from pharmaceutical companies?
Yes. Dr. Lardizabal received a total of $8,878 from 26 companies across 305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lardizabal's costs compare to other cardiologists in San Luis Obispo?
Dr. Lardizabal's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lardizabal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in San Luis Obispo
Browse cardiologists in San Luis Obispo ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Edwards Lifesciences Corporation Payments to Doctors
See all physicians who received payments from Edwards Lifesciences Corporation.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology